Efficacy and safety of switching to pasireotide in acromegaly patients controlled with peg

Skip to main navigation Skip to search Skip to main content

Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study

  • Ammar Muhammad
  • , Eva C. Coopmans
  • , Patric J.D. Delhanty
  • , Alof H.G. Dallenga
  • , Iain K. Haitsma
  • , Joseph A.M.J.L. Janssen
  • , Aart J. Van Der Lely
  • , Sebastian J.C.M.M. Neggers

Research output: Contribution to journalArticlepeer-review

53 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of switching to pasireotide in acromegaly patients controlled with pegvisomant and somatostatin analogues: PAPE extension study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

archive